Maryland hospital selects Wolters' ProVation order sets

Jeff Byers | | Health Exec | Economics
Union Hospital of Cecil County, a 122-bed nonprofit hospital located in Elkton, Md., has selected business intelligence software developer Wolters Kluwer Health’s ProVation order sets, powered by UpToDate Decision Support, as the organization's electronic order set program.

ProVation Order Sets is an order set authoring and management tool providing integration into clinical processes, the Minneapolis-based company stated. One Click Updates will alert users at Union to evidence that may trigger the need to modify order sets; enabling them to review updates and apply them across multiple order sets.

In addition to integrated links to UpToDate, ProVation order sets can link additional clinical resources based upon Union’s needs and preferences, the company added.

Jeff Byers

Related Content

Merck spends up to $2B to license new weight loss drug with potential heart benefits
Insulet wins $452M in lawsuit against rivals over medical device trade secrets
Medical device company cuts 70% of staff in push to meet Medtronic obligations
Cleerly’s momentum continues as AI specialists raise $106M
Operations manager, doctors charged in $70M imaging kickback scheme
Private-equity watchdog warns against nominating Marc Rowan as Treasury Secretary

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.